2011American Journal of Pharmacology and ToxicologyOpen access

Microtia After Ovulation Induction with Letrozole

E.

Open full text 1 citations

Abstract

Problem statement: Letrozole gained lots of interest over the past decayed as a medication for ovulation induction to achieve monofollicular results, although few retrospective analysis of congenital anolamalies detected for babies who were conceived via this medication; the dispute still exist and the need for large multicenter studies are needed to resolve this issue.Approach: In the current report; we report a case of microtia who was conceived as a result of ovulation induction with letrozole.Results: This case draws our attention to the safety of letrozole as an ovulation induction medication.Conclusion: The reported case here mandates that babies delivered as a consequence of ovulation induction with aromatase inhibitors should be examined antenatal and postnatally for possible congenital anomalies and to be reported to settle the argument weather theses medications are safe or not in term of ovulation induction.

Open-access reader

About this research paper

What this paper is about

Problem statement: Letrozole gained lots of interest over the past decayed as a medication for ovulation induction to achieve monofollicular results, although few retrospective analysis of congenital anolamalies detected for babies who were conceived via this medication; the dispute still exist and the need for large multicenter studies are needed to resolve this issue.Approach: In the current report; we report a case of microtia who was conceived as a result of ovulation induction with letrozole.Results: This case draws our attention to the safety of letrozole as an ovulation induction medication.Conclusion: The reported case here mandates that babies delivered as a consequence of ovulation induction with aromatase inhibitors should be examined antenatal and postnatally for possible congenital anomalies and to be reported to settle the argument weather theses medications are safe or not in term of ovulation induction.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Problem statement: Letrozole gained lots of interest over the past decayed as a medication for ovulation induction to achieve monofollicular results, although few retrospective analysis of congenital anolamalies detected for babies who were conceived via this medication; the dispute still exist and the need for large multicenter studies are needed to resolve this issue.Approach: In the current report; we report a case of microtia who was conceived as a result of ovulation induction with letrozole.Results: This case draws our attention to the safety of letrozole as an ovulation induction medication.Conclusion: The reported case here mandates that babies delivered as a consequence of ovulation induction with aromatase inhibitors should be examined antenatal and postnatally for possible congenital anomalies and to be reported to settle the argument weather theses medications are safe or not in term of ovulation induction.

Key concepts: Letrozole, Ovulation induction, Ovulation, Medicine, Aromatase inhibitor, Pregnancy, Aromatase, Gynecology

Related papers

Back to paper searchBrowse research topicsOriginal source
Microtia After Ovulation Induction with Letrozole — Research Paper | ScholarLens